ArticleFrontiers in oncology2022

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma.

Hongmei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.